Sixteen Years of Treatment with Pasteurized Human Clotting Factor Concentrates in Children and Adolescents: A Pharmacosurveillance Investigation Comprising 727 Patient Years
W. Muntean(Medical University of Graz), Karl Zwiauer(University of Vienna), Werner Streif(Innsbruck Medical University), Christoph Male(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Peter B. Kurnik(Klinikum Klagenfurt), Klaus Schmitt(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Jutta Falger, Johann Wank(St Anna Children's Hospital), Rudolf Schwarz(Universität Hamburg), Werner Zenz(Medical University of Graz)
Cited by 5
Related Papers
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
|Journal of Clinical Oncology|2005|347
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|344